M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 3, 2026
March 3, 2026
71519a94-61da-456b-b457-b4fbd7c82847
Related Documents
E2D(R1) Post-Approval Safety Data: Definitions and Standards for Management and Reporting of Individual Case Safety Reports
Guidance DocumentMarch 3, 2026Center for Drug Evaluation and Research
M15 General Principles for Model-Informed Drug Development
Guidance DocumentJune 2, 2026Center for Drug Evaluation and Research
Postapproval Pregnancy Safety Studies: Guidance for Industry
Guidance DocumentMay 8, 2026Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.